Page 3 - Reverse Transcriptase News Today

The crystal structure of a human endogenous reverse transcriptase has similarities to HIV reverse transcriptase, a well-known tractable drug target, which will help design drugs to treat cancer and other diseases, according to a study co-authored by a Rutgers researcher.

Lamivudine, a commonly-used antiretroviral drug for treating HIV, improves cognition in a mouse model of Down syndrome, according to the findings of a joint new study by researchers at the Centre for Genomic Regulation (CRG) and the IrsiCaixa AIDS Research Institute, a center jointly promoted by the "la Caixa" Foundation and the Department of Health of the Generalitat de Catalunya.

A new study provides evidence of the utility of serologic testing in helping to pick up children with long Covid following missed diagnoses of COVID-19.

Read user reviews, compare products & request pricing from manufacturers of enzymes, including DNA polymerase, restriction enzymes & protease

In a recent study posted to the bioRxiv* pre-print server, researchers at Cornell University College of Veterinary Medicine and the University of Illinois Urbana-Champaign compared the infection dynamics, pathogenicity, and tissue tropism of multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants in adult cats.

This product profile explains how HiScript III RT SuperMix for qPCR is the next generation reverse transcriptase supermix that improves the DNA synthesis.

Easter egg ‘hop’ spots Central Point Eggstravaganza: Kids can hunt for eggs, play games, take pictures with the Easter Bunny and more from 10 a.m. to noon Saturday, April 16, at Twin Creeks Park, 555 ...

Friday, April 8 Pear Blossom Festival: The 69th annual Rogue Valley Pear Blossom Festival will boast a full lineup of events the weekend of April 8 for the first time since the word “coronavirus” ente...

New clinical research shows that lamivudine, a reverse transcriptase inhibitor widely used in HIV therapy, stopped disease progression in 25% of patients with fourth-line metastatic colorectal cancer.

A study published in The Journal of Pathology reveals that many cancers that carry a poor prognosis express an altered form of human telomerase reverse transcriptase (hTERT), an enzyme that regulates the expression of multiple genes.